Newsroom

Healthcare Pharmaceutical Biotech

Stay informed with the latest in Healthcare, Pharmaceutical and Biotech press releases through our newsroom. Explore breaking updates, industry trends, and insights shaping these vital sectors—all in one place. Whether it’s innovation, regulatory changes, or breakthroughs, our newsroom keeps you connected to the stories that matter most.


Latest Press Releases

MedCognetics Collaborates With Laurel Bridge Software to Revolutionize Breast Cancer Screening and Diagnosis With Secure, Advanced AI Workflow Solutions
Healthcare & PharmaceuticalProduct Announcements

MedCognetics Collaborates With Laurel Bridge Software to Revolutionize Breast Cancer Screening and Diagnosis With Secure, Advanced AI Workflow Solutions

October 23, 2025 9:00 AM

MedCognetics, a pioneer in artificial intelligence (AI) for breast cancer screening, has teamed up with Laurel Bridge Software, a leader in medical imaging workflow solutions, to deliver an end-to-end solution for screening and diagnostic mammography. Laurel Bridge's proven workflow orchestration capabilities combined with MedCognetics' advanced AI platform enhances clinical efficiency, strengthens data security, and improves patient outcomes....

Read more
UTMD Reports Financial Performance for Third Calendar Quarter and Nine Months 2025
Healthcare & PharmaceuticalEarnings

UTMD Reports Financial Performance for Third Calendar Quarter and Nine Months 2025

October 23, 2025 9:00 AM

Utah Medical Products, Inc. (NASDAQ:UTMD) reports third quarter (3Q) and first nine months (9M) of calendar year 2025 financial results that were unusually hampered by global trade uncertainty. Currencies in this release are denoted as $ or USD = U.S. Dollars; AUD = Australia Dollars; £ or GBP = UK Pound Sterling; C$ or CAD = Canadian Dollars; and € or EUR = Euros. Currency amounts throughout this report are in thousands, except per share...

Read more
Stemtech Corporation Announces Entry Into India in a Joint Venture With Innoventure Dynamic LLP
Healthcare & PharmaceuticalCompany Update

Stemtech Corporation Announces Entry Into India in a Joint Venture With Innoventure Dynamic LLP

October 23, 2025 8:30 AM

"STEMTECH CORPORATION", the global leader and pioneer in stem cell nutrition, is proud to announce a key strategic agreement to open a joint venture in India with "INNOVENTURE DYNAMIC LLP". "STEMTECH HEALTHSCIENCES INDIA PRIVATE LIMITED" will be under the corporate structure of Stemtech Corporation, a Nevada USA company (OTCQB:STEK). The India Market Stemtech Corporation Chairman & CEO, Charles S. Arnold, states "India has always been a large...

Read more
VSee Health Strengthens Balance Sheet With The Elimination of Debt
Healthcare & PharmaceuticalCompany Update

VSee Health Strengthens Balance Sheet With The Elimination of Debt

October 23, 2025 8:06 AM

VSee Health, Inc. (Nasdaq:VSEE), a pioneering force in telehealth innovation, recently announced record-setting revenue growth. However, the Company has also been able to eliminate over $5M in legacy SPAC debt as it continues to strengthen its balance sheet and position itself for long term growth. Recent activity has significantly bolstered creditor confidence, creating a ripple effect that strengthens VSee Health's financial foundation. This...

Read more
Florence Connects 65,000+ Study Sites and 600+ Sponsors Worldwide - Unleashing the Next Era of Clinical Trial Intelligence
Healthcare & PharmaceuticalCompany Update

Florence Connects 65,000+ Study Sites and 600+ Sponsors Worldwide - Unleashing the Next Era of Clinical Trial Intelligence

October 23, 2025 8:00 AM

Florence Healthcare reinforced its position as the global leader in clinical trial operations with a major milestone: Florence Trial Operations Platform now connects 65,000 study sites spanning more than 600 sponsors across 90+ countries, forming the industry's largest network. Recognized as the #1 clinical trial technology for six consecutive years, Florence continues to set the standard for startup speed, workflow automation, and operational...

Read more
Cannadelic Global Summit Returns to St. Petersburg on Nov 9 with Groundbreaking Talks on Psychedelics, Love, and Liberation
Healthcare & PharmaceuticalAdvertorial

Cannadelic Global Summit Returns to St. Petersburg on Nov 9 with Groundbreaking Talks on Psychedelics, Love, and Liberation

October 23, 2025 8:00 AM

The Cannadelic Global Summit returns this fall to 2201 1st Ave S, St. Petersburg, FL, gathering the world's leading voices in psychedelics, mental health, sexuality, and social justice for a TED-style day of transformational talks. Headlining the summit is Dr. Angela Fisher, founder of Bionic Bloom Wellness Collective and the Neurodivergent Empowerment Institute (NEI), presenting her provocative keynote: From Blushing to Bonding: Erotic...

Read more
Cantargia to Participate in Upcoming Conferences
Healthcare & PharmaceuticalCompany Update

Cantargia to Participate in Upcoming Conferences

October 23, 2025 7:45 AM

Cantargia AB (publ) (Nasdaq Stockholm:CANTA)(STO:CANTA) today announced that management will participate in the following investor conferences. Stifel 2025 Healthcare Conference, New York City Presentation by Hilde Steineger, CEO. November 12 at 11.20 am ET (17.20pm CET). DnB Carnegie Nordic Healthcare Conference, Oslo Presentation by Hilde Steineger, CEO November 25, exact time is to be confirmed. Live webcasts and replays, when available, can...

Read more
Telomir Pharmaceuticals Reports New Data Showing Telomir-1 Resets Cancer's “Kill-and-Clean” Defense Systems in an Aggressive Prostate Cancer Model, Outperforming Rapamycin and Chemo
Healthcare & PharmaceuticalCompany Update

Telomir Pharmaceuticals Reports New Data Showing Telomir-1 Resets Cancer's “Kill-and-Clean” Defense Systems in an Aggressive Prostate Cancer Model, Outperforming Rapamycin and Chemo

October 23, 2025 7:30 AM

Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) ("Telomir" or the "Company"), a pre-clinical biotechnology company developing therapies that target the epigenetic roots of cancer, aging, and age-related disease, today reported new preclinical data from an in vivo study in mice bearing human aggressive prostate cancer tumors evaluating DNA-methylation changes in two key defense genes - CASP8 and GSTP1 - following treatment with oral Telomir-1,...

Read more
Moderna to Host Investor Event - Analyst Day
Healthcare & PharmaceuticalCompany Update

Moderna to Host Investor Event - Analyst Day

October 23, 2025 7:00 AM

Moderna, Inc. (Nasdaq:MRNA) today announced that it will host its Investor Event - Analyst Day at 9:00 a.m. ET on Thursday, November 20, 2025. The event will include presentations from management discussing Moderna's development and commercial strategy and key business considerations. A live webcast of the presentation will be available under "Events and Presentations" in the Investors section of the Moderna website Webcast:...

Read more
Zomedica Announces Launch of the Assisi Loop Lounge(R), Scientifically Backed tPEMF(TM) Therapy for Pets
Healthcare & PharmaceuticalCompany Update

Zomedica Announces Launch of the Assisi Loop Lounge(R), Scientifically Backed tPEMF(TM) Therapy for Pets

October 23, 2025 6:30 AM

Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), an animal health company offering innovative point-of-care diagnostic and therapeutic products for equine and companion animals, today announced the launch of the Assisi Loop Lounge, a next-generation targeted pulsed electromagnetic field (tPEMF) therapy bed delivering full-body treatment and luxurious comfort for pets, now featuring unlimited uses and a lifetime warranty to provide...

Read more
Dr. Malini Saba Champions Menstrual Equity Through Elara Pads
Healthcare & PharmaceuticalCompany Update

Dr. Malini Saba Champions Menstrual Equity Through Elara Pads

October 23, 2025 5:40 AM

Dr. Malini Saba, global entrepreneur, philanthropist, and advocate for women's empowerment, has launched Elara Pads, a line of biodegradable and affordable sanitary pads designed to transform girls' access to education and dignity worldwide. For Dr. Saba, Elara is not just a product-it's a movement. "Too many girls miss school because they lack something as basic as sanitary pads," says Dr. Saba. "If we can change that, we can change the...

Read more
Invitation to Presentations of Senzime's Third Quarter 2025 Report
Healthcare & PharmaceuticalCompany Update

Invitation to Presentations of Senzime's Third Quarter 2025 Report

October 23, 2025 5:15 AM

Senzime (STO:SEZI)(OTCQX:SNZZF) - Senzime invites investors, analysts, and media to a webcast presentation of the third quarter report for 2025 on Oct 29, 09:00 CEST. The report will be published during the morning of the same day. The webcast presentation will be held by Philip Siberg, CEO of Senzime and the recordiing will be available on Senzime's website https://www.senzime.com/investors In the afternoon of the same day, Gustaf Meyer,...

Read more
LICORbio Strengthens Global Research Engagement With Bioz Prime Badges and Bioz Content Hub
Healthcare & PharmaceuticalPartnerships

LICORbio Strengthens Global Research Engagement With Bioz Prime Badges and Bioz Content Hub

October 23, 2025 4:00 AM

Bioz, Inc., the industry-standard AI citation solution built to showcase scientific credibility and drive supplier sales performance, is proud to announce its continued collaboration with LICORbio, a global pioneer in fluorescence imaging technologies. By integrating Bioz Badges and a Bioz Content Hub into their digital ecosystem, LICORbio is elevating both customer engagement and internal sales effectiveness. The integration of Bioz Prime...

Read more
Interim Report January-September 2025
Healthcare & PharmaceuticalEarnings

Interim Report January-September 2025

October 23, 2025 1:50 AM

XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) Third quarter 2025 (Jul-Sep) Net sales amounted to SEK 189.1 million (198.5), corresponding to growth of -5 percent in SEK and 1 percent in local currencies. Organic growth amounted to -1 percent in local currencies. Organic growth, excluding revenue from heart trials, was positive at 6 percent in local currencies. The Abdominal business area delivered sales growth of 47 percent in local...

Read more
IRLAB: Invitation To The Interim Report For Q3 2025 Presentation And Webcast
Healthcare & PharmaceuticalCompany Update

IRLAB: Invitation To The Interim Report For Q3 2025 Presentation And Webcast

October 23, 2025 1:15 AM

IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A)(STO:IRLAB-A)(FRA:6IRA), a company discovering and developing novel treatments for Parkinson's disease, today announced that the company will hold a presentation in conjunction with the publication of the interim report for the period January - September 2025. The interim report will be published on Wednesday, October 29 at 07:00 CEST. The presentation will be held on October 29, 2025, at 10:00...

Read more
Did DEA's Anne Milgram Get Caught in Her Own Marijuana Criminal Algorithms?
Healthcare & PharmaceuticalCompany Update

Did DEA's Anne Milgram Get Caught in Her Own Marijuana Criminal Algorithms?

October 22, 2025 11:00 PM

Anne Milgram rose to prominence on a mission to "use data and algorithms to fight crime." As New Jersey's Attorney General from 2007 to 2010, she was praised for bringing analytics to law enforcement. But as DEA Administrator, Milgram's "data-driven" DEA became the very system of corruption, chaos, and incompetence she once claimed algorithms could prevent. DEA Anne Milgram A Digital Reformer Turned Bureaucratic Relic When President Biden...

Read more
New Survey Shows Nearly 70% of Older Adults in Singapore Underestimate Their Risk of Shingles; Only 1 in 4 Plans to Consult Their Doctor on Prevention
Healthcare & PharmaceuticalEnvironmental, Social and Governance

New Survey Shows Nearly 70% of Older Adults in Singapore Underestimate Their Risk of Shingles; Only 1 in 4 Plans to Consult Their Doctor on Prevention

October 22, 2025 9:48 PM

A new survey1 highlighted that 63% of older adults aged 50 years or over in Singapore recognised shingles, also known as herpes zoster, as a serious disease. However, two out of three underestimated their personal risk of contracting the disease. Despite the high awareness in this group, only 25% intended to discuss shingles prevention with their doctor within the next three months. The survey further showed that only 44% of respondents...

Read more
CORRECTION: MDaudit Spotlights the Vital Role of Health Information Professionals in Today's Evolving Healthcare Landscape
Healthcare & PharmaceuticalCompany Update

CORRECTION: MDaudit Spotlights the Vital Role of Health Information Professionals in Today's Evolving Healthcare Landscape

October 22, 2025 6:24 PM

MDaudit, an award-winning cloud-based continuous risk monitoring platform for RCM that enables the nation's premier healthcare organizations to minimize billing risks and maximize revenues, joins the American Health Information Management Association® (AHIMA) in a dynamic film series that shines a light on the vital work of health information (HI) professionals at the intersection of care, technology, and policy. Health Information: Making Every...

Read more
Epica International Appoints Alok K. Agrawal to Its Board of Directors
Healthcare & PharmaceuticalCompany Update

Epica International Appoints Alok K. Agrawal to Its Board of Directors

October 22, 2025 5:00 PM

Epica International announces the appointment of Alok K. Agrawal to its Board of Directors, effective immediately. Mr. Agrawal brings more than two decades of leadership experience spanning corporate strategy, venture capital, and industrial technology. At Celestica (NYSE: CLS), he served on the Executive Leadership Team and as Chief Strategy Officer, leading global initiatives that helped double company revenue and significantly increase...

Read more
3 in 5 HIM Leaders Report No FY26 Budget Set for TEFCA Onboarding Even as EHR Vendors Light Up National Exchange
Healthcare & PharmaceuticalConferences

3 in 5 HIM Leaders Report No FY26 Budget Set for TEFCA Onboarding Even as EHR Vendors Light Up National Exchange

October 22, 2025 5:00 PM

A flash survey of 97 Health Information Management (HIM) leaders indicates that 61% have no FY26 budget line for Trusted Exchange Framework and Common Agreement (TEFCA) onboarding and testing. The findings come as EHR and health IT vendors enable production TEFCA connectivity and national exchange participation expands. Key Results • Budgeting: 61% report no FY26 budget set or included for TEFCA onboarding/testing (including QHIN participation,...

Read more

Join the thousands of ACCESS Newswire customers today who are getting millions of views on their news.


Check out our flexible subscription and pay as you go pricing

and packages.

Use Code NEWS10 for 10% off  of your first purchase.


Latest Blog Posts

Visit our blogs for press release tips, media engagement

Strategies, and Product Comparisons.

Executive delivering prepared remarks from an earnings call script
By Jennifer Hammers • July 9, 2026
How to write earnings call prepared remarks that land — structure, length, the safe-harbor open, non-GAAP language, and building remarks around your strategy.
IR
By Brian Balbirnie • July 8, 2026
A practical earnings call preparation checklist for IR teams — the two-week runway, consensus, logistics, Q&A prep, and Reg FD-clean disclosure timing.
ACCESS Newswire guide on AI investor relations — how AI assistants read company earnings disclosures
By Jennifer Hammers • July 6, 2026
AI assistants read your earnings within minutes. Learn how IR teams make disclosures AI-readable — and how the LLM Citation Score measures your visibility.
A logo for accesswire next to a logo for rack
By Jennifer Hammers • June 21, 2026
Compare Muck Rack vs ACCESS Newswire on pricing, features, and alternatives. See how ACCESS Newswire adds distribution, pitching, and analytics.
A blue and white logo with a check mark next to it
By Jennifer Hammers • June 19, 2026
Compare Business Wire vs ACCESS Newswire on pricing and capabilities — and how ACCESS delivers comparable reach at a fraction of the cost.
A blue background with the word access on it
By Jennifer Hammers • June 14, 2026
Compare ACCESS Newswire vs Cision PR Newswire on pricing, features, reach, and reviews — and why companies are making the switch..
Show More




Discover the news
by Industry:


Need help with your PR Strategy?
Learn more about our
professional PR Services today:

.MEDIA PRO 
Want to get noticed
by the Media but don’t
know how? 

.TOTAL PRO

Need full support to 

Optimize your PR

Efforts?